{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Oncocyte Corporation"},"Symbol":{"label":"Symbol","value":"OCX"},"Address":{"label":"Address","value":"15 CUSHING, IRVINE, California, 92618, United States"},"Phone":{"label":"Phone","value":"+1 949 409-7600"},"Industry":{"label":"Industry","value":"Biotechnology: In Vitro & In Vivo Diagnostic Substances"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States, and it earns revenue from the sale of diagnostic tests."},"CompanyUrl":{"label":"Company Url","value":"https://www.oncocyte.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Ekkehard Sch√ºtz","title":"Chief Science Officer"},{"name":"Joshua Riggs","title":"President, Chief Executive Officer & Director"},{"name":"Yuh-Min Chiang","title":"Chief Technology Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}